From The Huffington Post (4/23):
A review of 10 randomized, double-blind, controlled trials on the
effectiveness of serotonin reuptake inhibitors for treating repetitive
behaviors in autism showed a publication
bias overstating the drug's benefits. Published trials found that the
drug yielded small improvements in patients with autism, but after
taking into account unpublished trials the improvement lost its
significance, researchers reported in the journal Pediatrics.
http://www.huffingtonpost.com/2012/04/23/autism-treatments_n_1441591.html?ref=mostpopular
No comments:
Post a Comment